|
BKNM-1001-5K
N/A |
|
mPEG-NH2,MW:5000
|
￥Member visible
|
|
BK2020011837
CAS |
|
MXene 50% V2C film
|
￥Member visible
|
|
|
BKNM-1001-2k
N/A |
|
mPEG-NH2,MW:2000
|
￥Member visible
|
|
|
BK2020011838
12316-56-2 |
|
MXeneTi3C2 composite nano silver wire film
|
￥Member visible
|
|
|
BK2020011837
CAS |
|
MXene composite highly conductive
|
￥Member visible
|
|
|
BK2020040204
12316-56-2 |
|
Ti3C2 transparent film
|
￥Member visible
|
|
BKNM-R-DZN014
N/A |
|
Choline-NBD Choline-7-nitrobenzofurazan
|
￥Member visible
|
|
|
BKNM-810145P
384832-99-9 |
|
DOPE-NBD
|
￥Member visible
|
|
|
BK2020082402
CAS |
|
Three-dimensional porous Mxene Ti3C2TX
|
￥Member visible
|
|
|
BKNM-R-07021276
N/A |
|
DSPE-PEG-VLWLKNR phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021275
N/A |
|
DSPE-PEG-ANTPCGPYTHDCPVKR phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021274
N/A |
|
DSPE-PEG-PQNSKIPGPTFLDPH phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021273
N/A |
|
DSPE-PEG-CTVALPGGYVRVC phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020032301
CAS |
|
mxene modified conductive flexible printed circuit with high conductivity and good adhesion
|
￥Member visible
|
|
|
BKNM-R-07021272
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021271
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020032601
CAS |
|
MXene sticky water-based ink
|
￥Member visible
|
|
|
BKNM-R-07021270
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020050402
CAS |
|
V2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021269
N/A |
|
DSPE-PEG-c-dGHCitGPQ-c phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021268
N/A |
|
DSPE-PEG-VRPMPLQ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020050401
CAS |
|
Ti3C2 Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021267
N/A |
|
DSPE-PEG-LSLERFLRCWSDAPA phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021265
N/A |
|
DSPE-PEG-αCD19 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021264
N/A |
|
DSPE-PEG-VTLTYEFAAGPRD phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021263
N/A |
|
DSPE-PEG-Anti-HER2 Fab′ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021262
N/A |
|
DSPE-PEG-αCD20mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020071007
CAS |
|
Ti2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021261
N/A |
|
DSPE-PEG-Anti-rat CC531mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021258
N/A |
|
DSPE-PEG-Fab’of C225 mAb(cetuximab) phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021256
N/A |
|
DSPE-PEG-mAb 2C5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021255
N/A |
|
DSPE-PEG-scFv(HD37-CCH) phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
